BIOMAT Database Logo BIOMAT Database Logo

Somatostatin cerebrospinal fluid levels in dementia. 1991

A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Department of Neurology, Valle Hebron General Hospital, Barcelona, Spain.

Somatostatin levels were measured in cerebrospinal fluid of patients with Alzheimer's disease, multi-infarct dementia and normal pressure hydrocephalus and compared with levels from a normal control group. All pathological groups showed a statistically significant decrease of somatostatin with respect to the control group, but no significant differences were found amongst them. A negative correlation was found between the Mini Mental State Test and the somatostatin levels in Alzheimer's disease patients but not in the other groups. Our results confirm that the lower levels of somatostatin in cerebrospinal fluid are not specific to Alzheimer's disease and indicate that the decrease found in all the groups is probably the result of neuronal destruction or damage in the diseases examined.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006850 Hydrocephalus, Normal Pressure A form of compensated hydrocephalus characterized clinically by a slowly progressive gait disorder (see GAIT DISORDERS, NEUROLOGIC), progressive intellectual decline, and URINARY INCONTINENCE. Spinal fluid pressure tends to be in the high normal range. This condition may result from processes which interfere with the absorption of CSF including SUBARACHNOID HEMORRHAGE, chronic MENINGITIS, and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp631-3) Hakim Syndrome,Normal Pressure Hydrocephalus,Hakim's Syndrome,Hydrocephalus, Normal-Pressure,NPH (Normal Pressure Hydrocephalus),Hakim Syndromes,Hakim's Syndromes,Hakims Syndrome,NPHs (Normal Pressure Hydrocephalus),Syndrome, Hakim,Syndrome, Hakim's,Syndromes, Hakim,Syndromes, Hakim's
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D015161 Dementia, Multi-Infarct Loss of higher cortical functions with retained awareness due to multiple cortical or subcortical CEREBRAL INFARCTION. Memory, judgment, attention span, and impulse control are often impaired, and may be accompanied by PSEUDOBULBAR PALSY; HEMIPARESIS; reflex abnormalities, and other signs of localized neurologic dysfunction. (From Adams et al., Principles of Neurology, 6th ed, p1060) Lacunar Dementia,Multi-Infarct Dementia,Dementia Multi-Infarct,Dementia, Multiinfarct,Lacunar Dementias,Dementia Multi Infarct,Dementia Multi-Infarcts,Dementia, Lacunar,Dementia, Multi Infarct,Dementias, Lacunar,Dementias, Multi-Infarct,Dementias, Multiinfarct,Multi Infarct Dementia,Multi-Infarct Dementias,Multi-Infarct, Dementia,Multi-Infarcts, Dementia,Multiinfarct Dementia,Multiinfarct Dementias

Related Publications

A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Cerebrospinal fluid tau levels in frontotemporal dementia.
October 2005, Annals of neurology,
A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Somatostatin in cerebrospinal fluid.
January 1985, Bulletin of clinical neurosciences,
A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Cerebrospinal fluid somatostatin in delirium.
August 1989, Psychological medicine,
A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Somatostatin in human cerebrospinal fluid.
March 1977, The New England journal of medicine,
A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Cerebrospinal fluid somatostatin levels in febrile seizures and epilepsy in children.
February 2000, Neuropeptides,
A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia.
February 2000, Neurology,
A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.
May 2014, Dementia and geriatric cognitive disorders extra,
A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia.
September 2014, Journal of neurology,
A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Cerebrospinal fluid levels of somatostatin, corticotropin-releasing hormone and corticotropin in alcoholism.
July 1990, Acta psychiatrica Scandinavica,
A Molins, and R Catalán, and J Sahuquillo, and J M Castellanos, and A Codina, and R Galard
Characterization of the course of senile dementia of the Alzheimer type using cerebrospinal fluid levels of acetylcholinesterase and somatostatin.
September 1989, Acta neurologica Scandinavica,
Copied contents to your clipboard!